
Majority of Indians experienced no or only mild side effects after taking two doses of COVID-19 vaccines Covishield and Covaxin, a survey conducted across the country said.
A massive COVID-19 vaccination drive was launched in India on January 16, with two vaccines -- Covishield, manufactured by the Serum Institute of India, and Covaxin, manufactured by Bharat Biotech.
Community social media platform LocalCircles said that according to its nationwide survey, "70 per cent of Indians after taking the first dose of Covishield and 64 per cent with Covaxin experienced no or mild side effects."
Similarly, 75 per cent inoculated with the second dose of Covishield and 78 per cent with the second dose of Covaxin experienced no or mild side effects, it added.
However, 30 per cent of those who were given the first dose of Covishield experienced side effects. Out of this, 29 per cent experienced fever and 1 per cent reported getting COVID infection, the survey said.
Thirty per cent of those who took the first dose of Covaxin experienced fever while 1 per cent reported having a post vaccine COVID infection, it added.
Read more at: https://economictimes.indiatimes.com/news/india/majority-of-indians-experience-no-or-mild-side-effects-post-2-doses-of-covid-vax-survey/articleshow/85621794.cms
Comments